Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Cell Pouch is well tolerated and shows signs of efficacy in type 1 diabetes patient

July 23, 2019

Rpxds identifies dual FTO/COMT inhibitors

July 22, 2019

Asahi Kasei Pharma discovers prostanoid EP4 receptor agonists

July 22, 2019

TRAF3 conditional knockout model points to TRAF3 degradation as a target for preventing osteoporosis

July 19, 2019

Midatech reports data from first-in-human study of MTX-102 in type 1 diabetes

July 19, 2019

Phase I study of Novo Nordisk's NNC-0247-0829 begins

July 19, 2019

Seelos submits IND for phase IIb/III study of SLS-005 for Sanfilippo syndrome

July 18, 2019

Teplizumab delays progression to clinical type 1 diabetes in relatives at risk

July 17, 2019

Synlogic reports topline data from phase I/IIa study of SYNB-1618 in patients with PKU

July 16, 2019

AVROBIO announces first kidney biopsy results and additional data for AVR-RD-01

July 16, 2019

Popular Stories

University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Beijing Innocare Pharma Tech discloses new GSPT1 degradation inducers
BioWorld Science
Beijing Innocare Pharma Tech Co. Ltd. has synthesized new antibody-drug conjugates comprising antibody or antigen-binding fragment covalently linked to eukaryotic...